Find Funding Opportunities

Notice Date Informational Webinar PAR-16-219 NINDS Faculty Development Award Promote Diversity Neuroscience Research K01)" Notice Number: NOT-NS-17-017 Key Dates Release Date:   February 10, 2017 Related Announcements PAR-16-219 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice to inform potential applicants mentors to the NINDS Faculty Development Award Promote Diversity Neuroscience Research K01) the date an upcoming webinar preparing applications this mechanism. webinar optional not required submission PAR-16-219. Webinar Information nbsp; You Need Know the NINDS Diversity Faculty Development K01 Award: Tips Preparing Application March 22, 2017, 2:00 - 3:00 p.m. Eastern Time Learn the NINDS K01 diversity faculty development award successful applicants a reviewer these mechanisms. webinar take through process putting together application the NINDS Faculty Development Award Promote Diversity Neuroscience Research K01) the from writing application anticipating responding reviewer's comments. Hear two K01 awardees how crafted applications, learn a reviewer common mistakes helpful tips. webinar intended potential applicants mentors NINDS diversity K01 grants. register the webinar, please to: https://nih.webex.com/nih/onstage/g.php?MTID=eb57f85ff7f36b4aa3334f4b98…. registration link available the bottom the page. Inquiries Please direct inquiries to: Michelle Jones-London, PhD National Institute Neurological Disorders Stroke NINDS)  Telephone: 301-496-4188 Email: NINDSDiversityTraining@ninds.nih.gov nbsp;

Extension Expiration Date PAR-14-287 NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-17-012 Key Dates Release Date: February 6, 2017 Related Announcements PAR-14-287 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-287 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U44)" be extended one receipt cycle. additional non-AIDS application due date July 18, 2017, AIDS AIDS-related applications due date September 7, 2017 been added this FOA. FOA expires September 8, 2017. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) January 7, 2015; 7, 2015; September 7, 2015; 7, 2016; September 7, 2016; May 7, 2017; September 7, 2017, 5:00 PM local time applicant organization. types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017 Advisory Council Review 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018 Earliest Start Date(s) July 2015 Expiration Date September 8, 2017 other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D., National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov nbsp;

Extension Expiration Date PAR-14-288 NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics UH2/UH3)" Notice Number: NOT-NS-17-013 Key Dates Release Date: February 6, 2017 Related Announcements PAR-14-288 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-288 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics UH2/UH3)" be extended one receipt cycle. additional non-AIDS application due date July 18, 2017, AIDS AIDS-related applications due date September 7, 2017 been added this FOA. FOA expires September 8, 2017. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) January 7, 2015; 7, 2015; September 7, 2015; 7, 2016; September 7, 2016; May 7, 2017; September 7, 2017, 5:00 PM local time applicant organization. types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017 Advisory Council Review 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018 Earliest Start Date(s) July 2015 Expiration Date September 8, 2017 other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D., National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov nbsp;

Extension Expiration Date PAR-14-289 NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-17-014 Key Dates Release Date: February 6, 2017 Related Announcements PAR-14-289 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-289 NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)" be extended one receipt cycle. additional non-AIDS application due date July 18, 2017, AIDS AIDS-related applications due date September 7, 2017 been added this FOA FOA expires September 8, 2017. Key Dates table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) January 7, 2015; 7, 2015; September 7, 2015; 7, 2016; September 7, 2016; May 7, 2017; September 7, 2017, 5:00 PM local time applicant organization. types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017 Advisory Council Review 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018 Earliest Start Date(s) July 2015 Expiration Date September 8, 2017 other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D., National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov  

Notice Extend Expiration Date PAR-14-208 NINDS Renewal Awards SBIR Phase II Grants Phase IIB) Exploratory Clinical Trials Clinical Research R44)" Notice Number: NOT-NS-17-015 Key Dates Release Date: February 6, 2017 Related Announcements PAR-14-208 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-208 quot;NINDS Renewal Awards SBIR Phase II Grants Phase IIB) Pre-Clinical Research R44)" be extended one receipt cycle.  additional application due date, September 5, 2017, been added this FOA.  FOA expires September 6, 2017. Key Dates Table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply, 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Standard AIDS dates apply, 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date September 6, 2017 nbsp; other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Stephanie Fertig, MBA National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: fertigs@ninds.nih.gov nbsp;

Notice Extend Expiration Date PAR-14-209 NINDS Renewal Awards SBIR Phase II Grants Phase IIB) Pre-Clinical Research R44)" Notice Number: NOT-NS-17-016 Key Dates Release Date: February 6, 2017 Related Announcements PAR-14-209 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-209 quot;NINDS Renewal Awards SBIR Phase II Grants Phase IIB) Pre-Clinical Research R44)" be extended one receipt cycle.  additional application due date, September 5, 2017, been added this FOA.  FOA expires September 6, 2017. Key Dates Table updated accordingly: Part 1. Overview Information Key Dates Application Due Date(s) Standard dates apply, 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) Standard AIDS dates apply, 5:00 PM local time applicant organization. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review Standard dates apply Advisory Council Review Standard dates apply Earliest Start Date Standard dates apply Expiration Date September 6, 2017 nbsp; other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Stephanie Fertig, MBA National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: fertigs@ninds.nih.gov nbsp;

Notice Extension Expiration Date PAR-14-286 NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)" Notice Number: NOT-NS-17-011 Key Dates Release Date: February 3, 2017 Related Announcements PAR-14-286 Issued National Institute Neurological Disorders Stroke NINDS) Purpose purpose this Notice to inform interested applicants the expiration date the Funding Opportunity Announcement FOA) PAR-14-286 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)" be extended one receipt cycle. additional non-AIDS application due date July 18, 2017, AIDS AIDS-related applications due date September 7, 2017 been added this FOA. FOA expires September 8, 2017. Key Dates table updated accordingly: Part 1. Overview Information nbsp; Key Dates nbsp; Application Due Date(s) October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, 5:00 PM local time applicant organization. All types non-AIDS applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. AIDS Application Due Date(s) January 7, 2015; 7, 2015; September 7, 2015; 7, 2016; September 7, 2016; May 7, 2017; September 7, 2017, 5:00 PM local time applicant organization. types AIDS AIDS-related applications allowed this funding opportunity announcement due these dates. Applicants encouraged apply early allow adequate time make any corrections errors found the application during submission process the due date. Scientific Merit Review February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017 Advisory Council Review 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018 Earliest Start Date(s) July 2015 Expiration Date September 8, 2017 other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Chris Boshoff, Ph.D., National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: chris.boshoff@nih.gov

Notice Reissuance PAR-16-106 Change Due Dates R21 Applications the Assessment Zika Virus ZIKV) Complications Notice Number: NOT-HD-16-036 Key Dates Release Date: December 14, 2016 Related Announcements NOT-HD-16-033 PAR-16-106     Issued Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Institute Allergy Infectious Diseases NIAID) National Institute Biomedical Imaging Bioengineering NIBIB) National Institute Dental Craniofacial Research NIDCR) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Purpose Eunice Kennedy Shriver National Institute Child Health Human Development NICHD), other NIH Institutes Centers ICs) listed above, announces PAR-16-106 quot;Rapid Assessment Zika Virus ZIKV) Complications R21)" being reissued. reissued FOA use standard application due dates, the timeframes review, council award dates now align standard NIH practices.  the reissuance the FOA, Zika-related R21 applications no longer accepted a rolling basis.  last day submit quot;rapid" R21 under PAR-16-106 be January 13, 2017.  After date, R21 applications be submitted the reissued FOA standard due dates. goal PAR-16-106 been respond quickly the public health emergency, reviewing applications rapidly, making timely awards support much needed projects.  a result this effort grants awarded support number highly meritorious projects were particularly urgent time-sensitive.  participating ICs) intend continue commitment supporting Zika research, applications no longer accepted a rolling basis. every NIH Institute Office had participated PAR-16-106 participate the re-issued FOA, there other FOAs support Zika projects related their research interests priorities.  example, PA-16-141 invites applications the quot;Development Anima Models Related Biological Materials Research R21).”  NOT-HL-16-466 lists FOAs addressing Zika virus related blood supply safety transfusion research. Zika-related FOAs be found searching NIH Guide Grants Contracts at: http://grants.nih.gov/funding/index.htm. addition, Zika-related applications also submitted response one the NIH-wide parent FOAs. Potential applicants strongly encouraged contact Scientific/Research staff before submitting application determine whether not proposed work within intended scope this program. Inquiries Please direct inquiries to: Nahida Chakhtoura MD, MsGH Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-435-6872 Email: nahida.chakhtoura@nih.gov Julia L. Zehr, Ph. D. National Institute Mental Health NIMH) Telephone: 301-443-1617 Email: zehrj@mail.nih.gov Wong, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone:  301-496-1431 Email:  wongm@ninds.nih.gov Lillian Shum, PhD National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-0618 Email:  ShumL@mail.nih.gov Mark Challberg, PhD National Institute Allergy Infectious Diseases NIAID) Phone: 301-496-7453 Email: MCHALLBERG@niaid.nih.gov George McKie, DVM, PhD National Eye Institute NEI) Telephone: 301-435-8152 Email: mckiegeo@nei.nih.gov Šeila Selimovic, Ph.D. National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4577 Email:  Seila.Selimovic@nih.gov  Simone Glynn, M.D., M.P.H. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0065 Email: glynnsa@nhlbi.nih.gov Stephanie Murphy, V.M.D., Ph.D. Office Research Infrastructure Programs Telephone: 301-451-7818 Email: stephanie.murphy@nih.gov

Notice an Informational Webinar RFA-NS-17-017 Frontotemporal Degeneration FTD) Sequencing Consortium: Discovery, Replication Validation UG3/UH3)" Notice Number: NOT-NS-17-010 Key Dates Release Date: December 12, 2016   Related Announcements RFA-NS-17-017        Issued National Institute Neurological Disorders Stroke NINDS) Purpose National Institute Neurological Disorders Stroke NINDS) hold pre-application informational webinar December 20, 2016 11:00-1:00 pm ET the Funding Opportunity Announcement FOA) RFA-NS-17-017, entitled quot;Frontotemporal Degeneration FTD) Sequencing Consortium: Discovery, Replication Validation UG3/UH3)". webinar provide brief introduction the FOA, highlight key apsects requirements the different phases this grant mechanism. Information how join webinar video audio coordinates, including passwords) provided below: Join WebEx meeting nbsp; https://nih.webex.com/join/sutherlandmnih.gov nbsp; |  622 274 563 nbsp; nbsp; nbsp; Join phone  1-650-479-3208 Call-in toll number US/Canada)  1-877-668-4493 Call-in toll-free number US/Canada)  Access code: 622 274 563  Global call-in numbers  |  Toll-free calling restrictions  nbsp; Participation this webinar, although encouraged, optional is required the submission an application. Inquiries Please direct inquiries to: Margaret Sutherland, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 Email: sutherlandm@ninds.nih.gov

Notice Encourage Eligible NIH BRAIN Initiative Awardees Apply Administrative Supplements Promote Diversity, PA-16-288 " Research Supplements Promote Diversity Health Related Research Admin Supp)" Notice Number: NOT-MH-17-008 Key Dates Release Date: December 6, 2016 Related Announcements notice supersedes NOT-MH-17-004 PA-16-288 RFA-MH-15-200 RFA-MH-15-225 RFA-NS-15-003 RFA-NS-15-004 RFA-NS-15-005 RFA-NS-15-006 RFA-NS-15-008 RFA-EB-15-006 RFA-EY-16-001 RFA-MH-16-750 RFA-MH-16-775 RFA-MH-16-810 RFA-MH-16-815 RFA-NS-16-006 RFA-NS-16-007 RFA-NS-16-008 RFA-NS-16-009 RFA-NS-16-010 Issued National Institute Mental Health NIMH) National Institute Biomedical Imaging Bioengineering NIBIB) National Eye Institute NEI) National Institute Neurological Disorders Stroke NINDS) Purpose revised Notice replaces NOT-MH-17-004 include four institutes participating the administrative supplement notice. Notice  encourages eligible awardees the BRAIN Initiative community apply administrative supplements response PA-16-288, Research Supplements Promote Diversity Health-Related Research."  NIH a strong interest the diversity the NIH-funded workforce NOT-OD-15-053 details) encourages institutions diversify student populations enhancing participation individuals groups identified nationally underrepresented the biomedical, clinical, behavioral, social sciences NOT-OD-15-089 categories definitions). BRAIN Initiative 2025 report stated the BRAIN Initiative should a catalyst will drive outstanding young people enter area their most creative career stage."  NIH diversity supplement program offers opportunity existing BRAIN awardees request additional funds train mentor next generation researchers underrepresented groups will contribute advancing goals the BRAIN Initiative. Principal Investigators PIs) active BRAIN Initiative research program grants thus encouraged identify individuals groups nationally underrepresented support mentor under auspices the administrative supplement program promote diversity. Individuals the identified groups eligible throughout continuum high school the faculty level. activities proposed the supplement application must fall within scope the parent grant, both advance objectives the parent grant support research training professional development the supplement candidate. BRAIN Initiative PIs strongly encouraged incorporate training activities will help prepare supplement candidate conduct rigorous research relevant the goals the BRAIN Initiative 2025 Report. Educational goals the NIH component the BRAIN Initiative BRAIN 2025: Scientific Vision) include acquisition quantitative skills, appropriate and integration newly developed tools, technologies methods developed under BRAIN Initiative, consideration the ethical implications neuroscience research. BRAIN 2025 Report notes individuals should obtain robust grounding quantitative reasoning, principles, techniques during training.  special focus training quantitative neuroscience, i.e. theory statistics biologists, exposing physicists, engineers statisticians experimental neuroscience. BRAIN 2025 Report strongly encourages scientists cross traditional areas expertise conduct interdisciplinary research, acknowledges need attract investigators faculty recruits neuroscience quantitative disciplines, e.g., statistics, computer science, physics, mathematics, engineering.   facilitate identification applications, first sentence the application's Project Summary should state following: parent grant a BRAIN Initiative award. PI submitting administrative supplement enhance diversity response NOT-MH-17-004. Awarding Institutes have specific practices diversity research supplement requests augment requirements described PA-16-288.  Therefore, consultation the Program Official the qualifying BRAIN award the individual named under Inquiries below strongly encouraged.  Supplement applications be evaluated the BRAIN Initiative research training committee, committee Program staff the Institutes Centers participating the NIH BRAIN Initiative.  Applications be considered according the following schedule: Application Due Date                                    Funding Decision December 1, 2016 February 15, 2017          March 31, 2017 February 16, 2017 March 30, 2017              15, 2017 April 1, 2017 May 31, 2017                          July 15, 2017 tracking purposes, applicants encouraged inform Dr. Nancy Desmond via email Nancy.Desmond@nih.gov) a diversity supplement application submitted. Please include PI name grant number this email. Inquiries Please direct inquiries to: Nancy L Desmond, Ph.D. National Institute Mental Health NIMH) Telephone: 301-443-3107 Email: Nancy.Desmond@nih.gov